Literature DB >> 22286912

Editorial: is macroprolactinemia just a diagnostic pitfall?

Marcello D Bronstein.   

Abstract

Mesh：

Year:  2012        PMID： 22286912     DOI： 10.1007/s12020-012-9608-0

Source DB:  PubMed          Journal:  Endocrine        ISSN： 1355-008X            Impact factor:   3.633


× No keyword cloud information.
  11 in total

1.  Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays.

Authors:  Thomas P Smith; Abdulwahab M Suliman; Michael N Fahie-Wilson; T Joseph McKenna
Journal:  J Clin Endocrinol Metab       Date:  2002-12       Impact factor: 5.958

2.  Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas.

Authors:  Felipe F Casanueva; Mark E Molitch; Janet A Schlechte; Roger Abs; Vivien Bonert; Marcello D Bronstein; Thierry Brue; Paolo Cappabianca; Annamaria Colao; Rudolf Fahlbusch; Hugo Fideleff; Moshe Hadani; Paul Kelly; David Kleinberg; Edward Laws; Josef Marek; Maurice Scanlon; Luis G Sobrinho; John A H Wass; Andrea Giustina
Journal:  Clin Endocrinol (Oxf)       Date:  2006-08       Impact factor: 3.478

Review 3.  Structural variants of prolactin: occurrence and physiological significance.

Authors:  Y N Sinha
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

4.  Extensive experience and validation of polyethylene glycol precipitation as a screening method for macroprolactinemia.

Authors:  J G Vieira; T T Tachibana; L H Obara; R M Maciel
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

5.  Clinical and radiological findings in macroprolactinemia.

Authors:  Serhat Isik; Dilek Berker; Yasemin Ates Tutuncu; Ufuk Ozuguz; Ferhat Gokay; Gonul Erden; Hatice Nursun Ozcan; Ferit Kerim Kucukler; Yusuf Aydin; Serdar Guler
Journal:  Endocrine       Date:  2011-12-21       Impact factor: 3.633

6.  Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay.

Authors:  Andrea Glezer; Carlos R J Soares; José G Vieira; Daniel Giannella-Neto; Maria Teresa C P Ribela; Vincent Goffin; Marcello D Bronstein
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

7.  Vertebral fractures in males with prolactinoma.

Authors:  Gherardo Mazziotti; Teresa Porcelli; Marilda Mormando; Ernesto De Menis; Antonio Bianchi; Carola Mejia; Tatiana Mancini; Laura De Marinis; Andrea Giustina
Journal:  Endocrine       Date:  2011-04-10       Impact factor: 3.633

8.  Pitfalls in pituitary diagnosis: peculiarities of three cases.

Authors:  A Glezer; C B D'Alva; L R Salgado; N R Musolino; P Serafini; J G Vieira; M D Bronstein
Journal:  Clin Endocrinol (Oxf)       Date:  2002-07       Impact factor: 3.478

9.  Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population.

Authors:  W A Hall; M G Luciano; J L Doppman; N J Patronas; E H Oldfield
Journal:  Ann Intern Med       Date:  1994-05-15       Impact factor: 25.391

10.  Anti-prolactin (PRL) autoantibodies suppress PRL bioactivity in patients with macroprolactinaemia.

Authors:  Naoki Hattori; Yasuhisa Nakayama; Kaori Kitagawa; Takashi Ishihara; Yasuhiko Saiki; Chiyoko Inagaki
Journal:  Clin Endocrinol (Oxf)       Date:  2007-08-06       Impact factor: 3.478
View more
  3 in total

1.  Macroprolactinemia in hyperprolactinemic infertile women.

Authors:  Krithika Thirunavakkarasu; Pinaki Dutta; Subbiah Sridhar; Lakhbir Dhaliwal; G R V Prashad; Shalini Gainder; Naresh Sachdeva; Anil Bhansali
Journal:  Endocrine       Date:  2013-03-30       Impact factor: 3.633

Review 2.  Concomitant myasthenia gravis and macroprolactinoma: the immunomodulatory role of prolactin and its potential therapeutic use.

Authors:  S M Harris; H M C Leong; R Chowdhury; C Ellis; John Brennan; I N Scobie
Journal:  Endocrine       Date:  2013-06-08       Impact factor: 3.633

3.  Sexual function and depressive symptoms in young women with elevated macroprolactin content: a pilot study.

Authors:  Robert Krysiak; Agnieszka Drosdzol-Cop; Violetta Skrzypulec-Plinta; Bogusław Okopien
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.